H.E.L Group appoints Allen Wang as General Manager of H.E.L China

Appointment follows successful expansion of operations in China and transition to direct sales model Supports next phase in H.E.L’s development as China becomes significant contributor to commercial growth London, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the appointment Wang Zilong (Allen Wang) [...]

Curio Bioscience Launches Industry’s First Unbiased, High-Resolution, Spatial Transcriptomics Solution

Curio’s technology expands access to spatial gene expression in tissue samples and addresses trade-offs between plex and resolution PALO ALTO, Calif. – Curio Bioscience today announced it has commenced commercial operations with the launch of Curio Seeker, the world’s first high-resolution, whole-transcriptome spatial mapping kit. Leveraging the Slide-seq technique that its academic co-founders created at the [...]

Dotmatics Scientific R&D Platform Introduces Built-in GraphPad Prism Integrations

Helps scientific organizations accelerate drug discovery programs by easily exporting large assay sets with faster decision making, using higher quality data Boston, MA – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced integration between its scientific R&D platform and its GraphPad Prism product, the world's leading analysis and graphing solution for scientific research.Now, [...]

Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute

New data on NovaSeq X Plus and workflow insights on Illumina Complete Long Reads unveiled at AGBT HOLLYWOOD, Fla. -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first NovaSeq X Plus system was recently delivered to the Broad Institute. Alex Aravanis, PhD, chief technology officer of [...]

Dolomite Bio announces re brand to Do Bio

Dolomite Bio launches new website, with exciting re brand, a new name and focus. The motivation behind the company’s name change to Do Bio reflects their evolution within the microfluidic, biology and life science space.The expertise behind Do bio’s technology is built on a strong foundation in the field of microfluidics. As the company has [...]

Dolomite Bio announces re brand to Do Bio

Dolomite Bio launches new website, with exciting re brand, a new name and focus. The motivation behind the company’s name change to Do Bio reflects their evolution within the microfluidic, biology and life science space.The expertise behind Do bio’s technology is built on a strong foundation in the field of microfluidics. As the company has [...]

Tecan collaborates with Element Biosciences to provide benchtop NGS

Männedorf, Switzerland – Tecan and Element Biosciences, Inc. – ­­ the developer of an innovative DNA sequencing platform disrupting genomics – are collaborating to offer a true benchtop NGS workflow with MagicPrep™ NGS* and the AVITI™ System. The collaboration will bring together Tecan’s automation expertise and Element Biosciences’ unique sequencing technologies, employing proprietary chemistries from [...]

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems FREMONT, Calif. – Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that it has entered into a strategic partnership with leading life science research and clinical diagnostics products company Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). Under the terms of the [...]

PacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions

End-to-End Solutions Planned to Support Key Customer Applications With Increased Cost Flexibility on Long-Read Sequencing Systems MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the commencement of a program intended to expand Multiplexed Arrays Sequencing (MAS-Seq) for new assays on the Sequel II/IIe and Revio™ sequencing systems. This program [...]

SEQLL ANNOUNCES CRADA WITH THE FBI

BILLERICA, Mass. -- SeqLL Inc. (“SeqLL”, NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced the establishment of a two-year Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Justice’s Federal Bureau of Investigation (FBI). Under this CRADA, SeqLL and the FBI Laboratory Division (FBI LD) will seek [...]

Access IBO on Knowledge Center